Terns Pharmaceuticals, Inc.
TERN
$6.53
$0.233.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.26% | 9.59% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.16% | 5.70% | |||
| Operating Income | 0.16% | -5.70% | |||
| Income Before Tax | -0.88% | -9.47% | |||
| Income Tax Expenses | -27.27% | 120.00% | |||
| Earnings from Continuing Operations | -0.77% | -9.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.77% | -9.67% | |||
| EBIT | 0.16% | -5.70% | |||
| EBITDA | 0.00% | -5.75% | |||
| EPS Basic | -0.65% | -9.42% | |||
| Normalized Basic EPS | -0.74% | -9.26% | |||
| EPS Diluted | -0.65% | -9.42% | |||
| Normalized Diluted EPS | -0.74% | -9.26% | |||
| Average Basic Shares Outstanding | 0.11% | 0.26% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||